Calithera Biosciences Statistics
Total Valuation
CALA has a market cap or net worth of $97,450. The enterprise value is -$23.69 million.
| Market Cap | 97,450 |
| Enterprise Value | -23.69M |
Important Dates
The last earnings date was Tuesday, August 29, 2023, after market close.
| Earnings Date | Aug 29, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
CALA has 4.87 million shares outstanding.
| Shares Outstanding | 4.87M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | n/a |
| Float | 4.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.00 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.60, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.60 |
| Quick Ratio | n/a |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 2.12 |
Financial Efficiency
Return on equity (ROE) is 2.07% and return on invested capital (ROIC) is -190.74%.
| Return on Equity (ROE) | 2.07% |
| Return on Assets (ROA) | 1.47% |
| Return on Capital (ROIC) | -190.74% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $52,750 |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -40.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.00% in the last 52 weeks. The beta is -0.17, so CALA's price volatility has been lower than the market average.
| Beta (1Y) | -0.17 |
| 52-Week Price Change | -20.00% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 44.43 |
| Average Volume (30 Days) | 1,132 |
Short Selling Information
The latest short interest is 417,277, so 8.56% of the outstanding shares have been sold short.
| Short Interest | 417,277 |
| Short Previous Month | 309,155 |
| Short % of Shares Out | 8.56% |
| Short % of Float | 8.72% |
| Short Ratio (days to cover) | 0.78 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -42.07M |
| Pretax Income | -39.65M |
| Net Income | 422,000 |
| EBITDA | -43.77M |
| EBIT | -44.02M |
| Earnings Per Share (EPS) | -$0.98 |
Balance Sheet
The company has $25.45 million in cash and $1.67 million in debt, giving a net cash position of $23.79 million or $4.88 per share.
| Cash & Cash Equivalents | 25.45M |
| Total Debt | 1.67M |
| Net Cash | 23.79M |
| Net Cash Per Share | $4.88 |
| Equity / Book Value | 20.39M |
| Book Value Per Share | 4.19 |
| Working Capital | 19.23M |
Cash Flow
In the last 12 months, operating cash flow was -$43.61 million and capital expenditures -$133,000, giving a free cash flow of -$43.74 million.
| Operating Cash Flow | -43.61M |
| Capital Expenditures | -133,000 |
| Free Cash Flow | -43.74M |
| FCF Per Share | -$8.76 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CALA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.08% |
| Shareholder Yield | -33.08% |
| Earnings Yield | 433.04% |
| FCF Yield | -44,885.58% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 15, 2022. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 15, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |